Esther Artime

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Rheumatoid Arthritis

Skeletal Muscle

Insulin Resistance

Top Venues

Pharmacoepidemiology and drug safety

Diabetes therapy : research, treatment and education of diabetes and related disorders

Pharmaceutical medicine

Endocrinology, diabetes & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Francisco Javier Ampudia-Blasco, Natalia Duque, Esther Artime, Elena Caveda, Erik Spaepen, Silvia Díaz-Cerezo, Miriam Rubio- de Santos, Daniel Callejo Velasco, Mª Pilar Bahíllo-Curieses
Which people with diabetes are treated with a disposable, half-unit insulin pen? A real-world, retrospective, database study in Spain. Endocrinology, diabetes & metabolism (2023)
Miriam Rubio-de Santos, Esther Artime, Natalia Duque, Silvia Díaz-Cerezo, Erik Spaepen, Ágata Carreño, Alberto Fernández
Profile of Patients with Diabetes Treated with Insulin Lispro 200 U/ml: A Real-World Study from Spain. Diabetes therapy : research, treatment and education of diabetes and related disorders 13 (6) (2022)
Esther Artime, Randip Kahlon, Ignacio Méndez, Tzuyung Kou, Macarena Garrido-Estepa, Nawab Qizilbash
Linking process indicators and clinical/safety outcomes to assess the effectiveness of abatacept (ORENCIA) patient alert cards in patients with rheumatoid arthritis. Pharmacoepidemiology and drug safety 29 (6) (2020)
Esther Artime, Nawab Qizilbash, Rafael Herruzo, Macarena Garrido-Estepa
Risk Minimisation Evaluation with Process Indicators and Behavioural or Health Outcomes in Europe: Systematic Review. Pharmaceutical medicine 34 (6) (2020)
Esther Artime, Irene Shui, Ignacio Mendez, Stephanie Tcherny-Lessenot, Pierre D'Arbigny, Noelia Alfaro, Nawab Qizilbash
Pre/post effectiveness evaluation of updated additional risk minimisation measures for an orphan disease: Myozyme (alglucosidase alfa) Safety Information Packet. Pharmacoepidemiology and drug safety 29 (1) (2019)